HOME Top Market Reports Contrast Injector Market by Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector Head, Tubing), Accessories), & Application (Radiology, Interventional Cardiology, Interventional Radiology) - Global Forecast to 2021

Contrast Injector Market by Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector Head, Tubing), Accessories), & Application (Radiology, Interventional Cardiology, Interventional Radiology) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: May 2017
Report Code: MD 5244

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The contrast injector market is projected to reach USD 636.1 Million by 2021 from USD 445.5 Million in 2016, growing at a CAGR of 7.4% during the forecast period. The contrast injector market growth can primarily be attributed to factors such as the large number of approvals for contrast agents in different geographies and increasing number of public and private diagnostic centers. On the other hand, the side effects and allergic reactions associated with contrast agents are expected to limit the market growth to a certain extent. In the coming years, the contrast media injector market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in the region can be attributed to the rising approvals for various contrast agents in Asia-Pacific countries, developing markets, and the growing presence of international players in this region. In addition, the availability of government support for research, high healthcare expenditures in APAC countries, rising aging population, and increasing cancer incidences are expected to support the growth of the Asia-Pacific contrast injector market.

On the basis of product, the contrast injector market is categorized into injector systems, consumables, and accessories. In 2016, the consumables segment is estimated to account for the largest share of the contrast injector market. This growth is mainly attributed to the recurring use of consumables in diagnostic procedures to maintain hygienic conditions. The injector systems segment is further divided into CT injector systems, MRI injector systems, and angiography injector systems. In 2016, the CT injector systems segment is expected to command the largest share of the market. The MRI injector systems segment is expected to grow at the highest CAGR during the forecast period. The consumables segment is further divided into injector heads, syringes, tubing, and other consumables (scan bags, valves, vials, and spikes). In 2016, the injector heads segment is estimated to account for the largest share of the consumables market. The injector heads segment is further categorized into single head injectors, dual head injectors, and syringeless injectors. The single head injectors segment is expected to command the largest share of the market, in 2016. The syringeless injectors segment is projected to grow at the highest CAGR during the forecast period.

On the basis of application, the contrast injector market is segmented into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to account for the largest share of the global market in 2016. Factors such as the increasing use of contrast agents in various diagnostic procedures/centers are expected to drive the contrast injectors market for radiology applications. The interventional cardiology segment is expected to grow at the highest CAGR during the forecast period.

On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America is estimated to account for the largest share of the contrast injector market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is expected to grow at the highest CAGR during the forecast period, and also serve as a revenue pocket for companies offering contrast injectors.

The prominent players in the global contrast injector market include Bracco Imaging S.p.A. (Italy), Bayer HealthCare (Germany), and Guerbet Group (France) in 2015. These companies are dominant in the market mainly due to their well-established presence in the field of contrast injector, presence in over 50 countries, high R&D investments, and strong sales and distribution force. Other players include Medtron AG (Germany), ulrich GmbH & Co. KG (Germany), GE Healthcare (U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), and Apollo RT Co., Ltd. (China).

Stakeholders of the Contrast Injector Market 

  • Contrast Injector Manufacturers and Distributors
  • Contrast Media/Contrast Agent Manufacturers and Distributors
  • Companies Manufacturing X-ray, CT, MRI, and Cath Lab Equipment
  • Niche Companies Manufacturing Novel Contrast Agents and Contrast Injectors
  • Healthcare Institutions (Hospitals, Academic Medical Centers, and Outpatient Clinics)
  • Radiology Centers
  • Medical Imaging & Nuclear Medicine Consultants
  • Health Insurance Players
  • Research and Consulting Firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This research report categorizes the global contrast injector market into the following segments:

Contrast Injector Market, by Product

  • Injector Systems
    • CT Injector Systems
    • MRI Injector Systems
    • Angiography Injector Systems
  • Consumables
    • Injector Heads
      • Single Head Injectors
      • Dual Head Injectors
      • Syringeless Injectors
    • Tubing
    • Syringe
    • Other Consumables
  • Accessories

Contrast Injector Market, by Application

  • Radiology
  • Interventional Cardiology
  • Interventional Radiology

Contrast Injector Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • EU-3
    • RoE
  • Asia-Pacific
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization option is available for the report:

Portfolio Assessment

Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies in the market.

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 16)
    2.1 Research Methodology Steps
           2.1.1 Secondary and Primary Research Methodology
                    2.1.1.1 Secondary Research
                               2.1.1.1.1 Key Data From Secondary Sources
                    2.1.1.2 Primary Research
                               2.1.1.2.1 Key Insights From Primary Sources
                    2.1.1.3 Key Industry Insights
           2.1.2 Market Size Estimation Methodology
           2.1.3 Research Design
           2.1.4 Market Data Validation and Triangulation
           2.1.5 Assumptions

3 Executive Summary (Page No. - 26)
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights (Page No. - 29)
    4.1 Contrast Injectors: Market Overview
    4.2 Contrast Injectors Market, By Application and  By Product
    4.3 Contrast Injectors Market, By Application and  By Region
    4.4 Geographic Snapshot: Contrast Injectors Market

5 Market Overview (Page No. - 32)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Large Number of Approvals for Contrast Agents
                    5.2.1.2 Increasing Number of Public and Private Diagnostic Centers
           5.2.2 Restraints
                    5.2.2.1 Risks Associated With Contrast Media Injectors
                    5.2.2.2 High Cost of Contrast Media Injectors and Consumables & Accessories
                    5.2.2.3 Reluctance to Adopt New Technology
           5.2.3 Opportunities
                    5.2.3.1 Technological Advancements in Contrast Media Injectors Arena
                               5.2.3.1.1 It-Enabled Solutions for Contrast Media Injectors
                               5.2.3.1.2 Syringeless and Dual-Head Injectors
                    5.2.3.2 Increasing Focus of Market Players on Contrast Media Injector Arena
           5.2.4 Challenges
                    5.2.4.1 Development of Gamma and Neutron Imaging Solutions
                    5.2.4.2 Shortage of and Need for Highly Skilled Professionals
                    5.2.4.3 Development of Biomarkers

6 Global Contrast Injectors Market, By Product (Page No. - 38)
    6.1 Introduction
    6.2 Injector Systems
           6.2.1 CT Injector Systems
           6.2.2 MRI Injector Systems
           6.2.3 Angiography Injector Systems
    6.3 Consumables
           6.3.1 Injector Heads
                    6.3.1.1 Single Head Injectors
                    6.3.1.2 Dual Head Injectors
                    6.3.1.3 Syringeless Injectors
           6.3.2 Syringes
           6.3.3 Tubing
           6.3.4 Other Consumables
    6.4 Accessories

7 Global Contrast Injectors Market, By Application (Page No. - 51)
    7.1 Introduction
    7.2 Radiology
    7.3 Interventional Cardiology
    7.4 Interventional Radiology

8 Contrast Injectors Market, By Region (Page No. - 57)
    8.1 Introduction
    8.2 North America
           8.2.1 U.S.
                    8.2.1.1 Increasing Number of Diagnostic Imaging Tests and Centers
                    8.2.1.2 Rising Prevalence of Chronic Diseases and Increasing Aging Population
                    8.2.1.3 Prevalence of Alzheimer’s Disease and Other Dementias
           8.2.2 Canada
                    8.2.2.1 Rising Aging Population, High Incidence of Cancer, CVD, and Diabetes
                    8.2.2.2 MRI and CT Examinations Likely to Boost the Market
                    8.2.2.3 Increasing Number of Cardiac Arrest Cases
    8.3 Europe
           8.3.1 Europe 3
                    8.3.1.1 Germany: Increasing Number of Diagnostic Imaging Procedures
                    8.3.1.2 France: Increasing Incidences and Prevalence of Cancer
                    8.3.1.3 U.K.: Lack of Sufficient Instruments
           8.3.2 RoE
                    8.3.2.1 Increased Focus of Market Players on RoE Countries
                    8.3.2.2 Russia: Initiatives By Government to Improve Healthcare
    8.4 Asia-Pacific
           8.4.1 Rise in Aging Population and Cancer Incidence
           8.4.2 Expansion of International Players in China and India
           8.4.3 Favorable Regulatory Changes in New Zealand and Australia
           8.4.4 Healthcare Reforms, Government Initiatives, and Investments in China
    8.5 Rest of the World
           8.5.1 Latin America
           8.5.2 The Middle East
           8.5.3 Africa

9 Competitive Landscape (Page No. - 92)
    9.1 Overview
    9.2 Market Share Analysis
           9.2.1 Bracco Imaging S.P.A
           9.2.2 Bayer Healthcare
           9.2.3 Guerbet Group
    9.3 Competitive Scenario
           9.3.1 Other Strategies
           9.3.2 Product Deployment
           9.3.3 Product Launch
           9.3.4 Market Developments (Product Approvals)

10 Company Profiles (Page No. - 98)
(Overview, Financial*, Products & Services, Strategy, and Developments)
     10.1 Bayer AG (Medrad Inc.)
     10.2 Bracco Imaging S.P.A.
     10.3 Guerbet Group
     10.4 Ulrich GmbH & Co. Kg.
     10.5 Nemoto Kyorindo Co., Ltd
     10.6 Sino Medical-Device Technology Co., Ltd. (SinoMDT)
     10.7 Apollo RT  Co., Ltd.
     10.8 Vivid Imaging
     10.9 Angiodynamics (Navilyst Medical, Inc)
     10.10 GE Healthcare

*Details Might Not Be Captured in Case of Unlisted Companies.

11 Appendix (Page No. - 117)
     11.1 Discussion Guide
     11.2 Knowledge Store: Marketsandmarkets Subscription Portal
     11.3 Introducing RT: Real-Time Market Intelligence
     11.4 Available Customizations
     11.5 Related Reports
     11.6 Author Details


List of Tables (69 Tables)

Table 1 Global Contrast Injectors Market Size, By Product, 2014–2021 (USD Million)
Table 2 Contrast Injector Systems Market Size, By Region, 2014–2021 (USD Million)
Table 3 Contrast Injector Systems Market Size, By Type, 2014–2021 (USD Million)
Table 4 Contrast CT Injector Systems Market Size, By Region, 2014–2021 (USD Million)
Table 5 Contrast MRI Injector Systems Market Size, By Region, 2014–2021 (USD Million)
Table 6 Contrast Angiography Injector Systems Market Size, By Region, 2014–2021 (USD Million)
Table 7 Contrast Injector Consumables Market Size, By Region, 2014–2021 (USD Million)
Table 8 Contrast Injector Consumables Market Size, By Type, 2014–2021 (USD Million)
Table 9 Contrast Injector Heads Market Size, By Region, 2014–2021 (USD Million)
Table 10 Contrast Injector Heads Market Size, By Type, 2014–2021 (USD Million)
Table 11 Single Head Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 12 Dual Head Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 13 Syringeless Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 14 Contrast Injector Syringes Market Size, By Region, 2014–2021 (USD Million)
Table 15 Contrast Injector Tubing Market Size, By Region, 2014–2021 (USD Million)
Table 16 Other Contrast Injector Consumables Market Size, By Region, 2014–2021 (USD Million)
Table 17 Contrast Injector Accessories Market Size, By Region, 2014–2021 (USD Million)
Table 18 Contrast Injectors Market Size, By Application, 2014–2021 (USD Million)
Table 19 Contrast Injectors Market Size for Radiology, By Region, 2014–2021 (USD Million)
Table 20 Contrast Injectors Market Size for Interventional Cardiology, By Region, 2014–2021 (USD Million)
Table 21 Contrast Injectors Market Size for Interventional Radiology, By Region, 2014–2021 (USD Million)
Table 22 Contrast Injector Market Size, By Region, 2014-2021 (USD Million)
Table 23 North America: Market Size, By Country, 2014-2021 (USD Million)
Table 24 North America: Contrast Injector Market Size, By Product, 2014-2021 (USD Million)
Table 25 North America: Market Size, By Injector System Type, 2014-2021 (USD Million)
Table 26 North America: Market Size, By Consumables Type, 2014-2021 (USD Million)
Table 27 North America: Market Size, By Injector Head Type, 2014-2021 (USD Million)
Table 28 North America: Contrast Injector Market Size, By Application, 2014-2021 (USD Million)
Table 29 U.S.: Market Size, By Product, 2014-2021 (USD Million)
Table 30 U.S.: Contrast Injector Market Size, By Injector System Type, 2014-2021 (USD Million)
Table 31 U.S.: Market Size, By Consumables Type, 2014-2021 (USD Million)
Table 32 U.S.: Contrast Injector Market Size, By Injector Head Type, 2014-2021 (USD Million)
Table 33 U.S.:  Market Size, By Application, 2014-2021 (USD Million)
Table 34 Canada: Market Size, By Product, 2014-2021 (USD Million)
Table 35 Canada: Market Size, By Injector System Type, 2014-2021 (USD Million)
Table 36 Canada: Market Size, By Consumables Type, 2014-2021 (USD Million)
Table 37 Canada: Market Size, By Injector Head Type, 2014-2021 (USD Million)
Table 38 Canada: Market Size, By Application, 2014-2021 (USD Million)
Table 39 Europe: Contrast Injector Market Size, By Country, 2014-2021 (USD Million)
Table 40 Europe: Market Size, By Product, 2014-2021 (USD Million)
Table 41 Europe: Market Size, By Injector System Type, 2014-2021 (USD Million)
Table 42 Europe: Market Size, By Consumables Type, 2014-2021 (USD Million)
Table 43 Europe: Contrast Injector Market Size, By Injector Head Type, 2014-2021 (USD Million)
Table 44 Europe: Market Size, By Application, 2014-2021 (USD Million)
Table 45 Europe 3: Contrast Injector Market Size, By Product, 2014-2021 (USD Million)
Table 46 Europe 3: Contrast Injector Market Size, By Injector System Type, 2014-2021 (USD Million)
Table 47 Europe 3: Market Size, By Consumables Type, 2014-2021 (USD Million)
Table 48 Europe 3: Contrast Injector Market Size, By Injector Head Type, 2014-2021 (USD Million)
Table 49 Europe 3: Market Size, By Application, 2014-2021 (USD Million)
Table 50 RoE: Contrast Injector Market Size, By Product, 2014-2021 (USD Million)
Table 51 RoE: Market Size, By Injector System Type, 2014-2021 (USD Million)
Table 52 RoE: Contrast Injector Market Size, By Consumables Type, 2014-2021 (USD Million)
Table 53 RoE: Contrast Injector Market Size, By Injector Head Type, 2014-2021 (USD Million)
Table 54 RoE: Market Size, By Application, 2014-2021 (USD Million)
Table 55 Asia-Pacific: Market Size, By Product, 2014-2021 (USD Million)
Table 56 Asia-Pacific: Contrast Injector Market Size, By Injector System Type, 2014-2021 (USD Million)
Table 57 Asia-Pacific: Market Size, By Consumables Type, 2014-2021 (USD Million)
Table 58 Asia-Pacific: Contrast Injector Market Size, By Injector Head Type, 2014-2021 (USD Million)
Table 59 Asia-Pacific: Contrast Injector Market Size, By Application, 2014-2021 (USD Million)
Table 60 RoW: Market Size, By Product, 2014-2021 (USD Million)
Table 61 RoW: Market Size, By Injector System Type, 2014-2021 (USD Million)
Table 62 RoW: Market Size, By Consumables Type, 2014-2021 (USD Million)
Table 63 RoW: Market Size, By Injector Head Type, 2014-2021 (USD Million)
Table 64 RoW: Market Size, By Application, 2014-2021 (USD Million)
Table 65 Key Player’s Ranking in the Contrast Injector Market (2016)
Table 66 Other Strategies, 2014–2016
Table 67 Product Deployment, 2014–2016
Table 68 Product Launch, 2013–2016
Table 69 Market Developments (Product Approvals), 2013–2016
 
 
List of Figures (32 Figures)
 
Figure 1 Research Methodology: Global Contrast Injectors Market
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Sampling Frame: Primary Research
Figure 4 Key Data From Primary Sources
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Research Design: Global Contrast Injectors Market
Figure 8 Data Triangulation Methodology
Figure 9 Contrast Injectors Market, By Product
Figure 10 Contrast Injectors Market Analysis, By Application, 2016 vs 2021
Figure 11 Asia-Pacific is Expected to Witness the Highest Growth in the Contrast Injectors Market During the Forecast Period
Figure 12 North America Estimated to Account for the Largest Market Share in 2016
Figure 13 Consumables Segment Estimated to Lead the Market in 2016
Figure 14 Radiology is Estimated to Be the Largest Application, 2016
Figure 15 Asia-Pacific to Witness Highest Growth During the Forecast Period
Figure 16 Drivers, Restraints, Opportunities & Challenges
Figure 17 The Consumables Segment is the Fastest-Growing Product Segment of the Global Contrast Injectors Market
Figure 18 Radiology to Account for the Largest Share of the Contrast Injectors Market, By Application (2016)
Figure 19 North America to Command the Largest Share of the Contrast Injector Market
Figure 20 North America: Contrast Injector Market Snapshot
Figure 21 Prevalence of Alzheimer's Disease in the U.S., By Age Group, 2015
Figure 22 Europe: Contrast Market Snapshot
Figure 23 Asia-Pacific: Contrast Injector Market Snapshot
Figure 24 RoW: Contrast Market Snapshot
Figure 25 Key Developments of the Prominent Players in the Contrast Injector Market (2013-2016)
Figure 26 Other Strategies Key Growth Strategy Adopted By Market Players From 2013 to 2016
Figure 27 Product Mix of the Prominent Players in the Contrast Injector Market
Figure 28 Bayer Healthcare: Company Snapshot
Figure 29 Bracco Imaging S.P.A: Company Snapshot (2015)
Figure 30 Guerbet Group: Company Snapshot (2015)
Figure 31 Angiodynamics: Company Snapshot (2015)
Figure 32 GE Healthcare: Company Snapshot 

The contrast injector market is projected to reach USD 636.1 Million by 2021 from 445.5 Million in 2016, growing at a CAGR of 7.4% during the forecast period. The contrast injector market growth can primarily be attributed to factors such as the large number of approvals for contrast agents in different geographies and increasing number of public and private diagnostic centers. On the other hand, the side effects and allergic reactions associated with contrast agents are expected to limit the market growth to a certain extent.

The global contrast injector market is segmented on the basis of application, product, and region. Based on application, the contrast injector market is segmented into radiology, interventional cardiology, and interventional radiology. The interventional cardiology segment is projected to grow at the highest CAGR during the forecast period. However, the radiology segment is expected to command the largest share of the contrast injector market in 2016.

Based on product, the market is categorized into injector systems, consumables, and accessories. The injector systems category is further segmented into CT injector systems, MRI injector systems, and angiography injector systems. The CT injector systems segment is expected to command the largest share of the market in 2016. The MRI injector systems segment is projected to grow at the highest CAGR during the forecast period. The consumables segment is expected to account for the largest share of the market in 2016. The growth of the consumables segment can largely be attributed to the recurring use in every procedure conducted. The consumables segment is further segmented into injector heads, syringes, tubing, and other consumables (scan bags, valves, vials, and spikes). The injector heads segment is estimated to account for the largest share of the consumables market in 2016. The injector heads segment is further divided into single head injectors, dual head injectors, and syringeless injectors. The single head injectors segment is expected to command the largest share of the market in 2016. The syringeless injectors segment is projected to grow at the highest CAGR during the forecast period.

Based on region, North America is expected to account for the largest share of the global contrast injector market. North America’s leadership position in the market can be attributed to the increase in the number of diagnostics imaging centers and tests, rising prevalence of chronic diseases, increasing aging population in the U.S., increasing number of cardiac arrests, and rising incidence of diseases. In the coming years, the contrast injector market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in the region can be attributed to the rising approvals for various contrast agents in Asia-Pacific countries, developing markets, and the growing presence of international players in this region. In addition, the availability of government support for research, high healthcare expenditure in APAC countries, increase in aging population, and increasing cancer incidences are expected to support the growth of the Asia-Pacific contrast injector market.

Contrast Injector Market

Key players in the global contrast injector market include Bracco Imaging S.p.A. (Italy), Bayer HealthCare (Germany), Guerbet Group (France), Medtron AG (Germany), ulrich GmbH & Co. KG (Germany), GE Healthcare (U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), and Apollo RT Co., Ltd. (China).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo